Agmatine as a treatment for neuropathic pain

Details Agmatine as a treatment for neuropathic pain Agmatine as a treatment for neuropathic pain

2000-02-10

2000-11-21

Krass, Frederick

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514937, 514866, A61K 31155

Patent

active

06150419&

ABSTRACT:
A treatment and composition for neuropathic pain by administering an effective amount of agmatine.

REFERENCES:
patent: 5352683 (1994-10-01), Mayer et al.
patent: 5534495 (1996-07-01), Pert et al.
patent: 5587454 (1996-12-01), Justice et al.
patent: 5677349 (1997-10-01), Gilad et al.
John J. Bonica, The Management of Pain, Second Edition, vol. 1, pp. 1-17, 1990.
Terence J. Coderre et al., Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence, pp 259-285, 1992.
Gad M. Gildad et al., Accumulation of exogenous polyamines in gerbil brain after ischemia, Molecular and Chemical Neuropathology, vol. 18, pp. 197-210, 1993.
Andy Dray et al., Pharmacology of chronic pain, TiPS, vol 15, pp. 190-197, 1994.
Clifford J. Woolf et al., The pathophysiology of chronic pain -increased sensitivity of low threshold A.beta.-fiber inputs, Current Opinion in Neurobiology 1994, 4:425-534.
Fernando Cervero et al, From acute to chronic pain: mechanisms and hypotheses, Progress in Brain Research, vol. 110, pp. 3-15, 1996.
Bradley S. Galer, MD, Neuropathic pain of peripheral origin: Advances in pharmacologic treatment, Neurology 45 (Suppl 9), pp. S17-S25, 1995.
Gilbert R. Gonzales, MD., Central Pain: Diagnosis and treatment strategies, Neurology 45 (Suppl 9), pp. S11-S16, 1995.
Anthony H. Dickenson, Central acute pain mechanisms, Annals of Medicine 27:223-227, 1995.
A. Dray et al, New Pharmacological strategies for pain relief, Annu. Rev. Pharmacol. Toxicol, pp. 36-253-80, 1996.
Gad M. Gilad et al, Agmatine treatment is neuroprotective in rodent brain injury models, Life Science, vol. 58, No. 2, pp pl 41-46, 1996.
Tinna M. Laughlin et al., Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors, International Association for the Study of Pain, pp. 253-260, 1997.
Brochure, The UCSF Pain Clinical Research Center (PCRC), 1997.
Brochure, Triggering Mechanism of Neuropathic Pain, 1997.
W.D. Willis et al., Neuroanatomy of the pain system and of teh pathways that modulate pain, Journal of Clinical Neurophysiology, vol. 14, No. 1, pp. 2-31, 1997.
Brochure, Pain Terms, pp. 210-211, (1997).
Chemical Abstracts, vol. 112, No. 11, issued Mar. 12, 1990, Ralph H. Loring, "Agmatine acts as an antagonist of neuronal nicotinic receptors", p. 145, column 2, abstract no. 92350w, br. J. Pharmacol., 99(1), pp. 207-11, see entire abstract.

Affiliated with

Also associated with

Rating

Agmatine as a treatment for neuropathic pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agmatine as a treatment for neuropathic pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agmatine as a treatment for neuropathic pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1257932